User:WatchesTheStars/Lore:Interdyne
 Interdyne Pharmaceuticals |
Other Names: Dyne, IDP |
Many well-known clinics and treatment facilities on the frontier are supplied by Interdyne Pharmaceuticals; a Sovereign Corporation specializing in advanced medicine, biotech, and synthetic drug development. While widely respected for breakthroughs like Sansufentanyl, critics question their ethics and blame them for conditions they now profit from treating. Interdyne maintains ties with nearly every major power in the sector, including Nanotrasen, SolFed, and even Syndicate-linked interests.
Interdyne Pharmaceuticals
“A Sovereign presence in every pulse and protocol”
Interdyne Pharmaceuticals is a Sovereign medical conglomerate with holdings that stretch from Core Sector capitals to the most remote edge-world colonies. In the Core, their name is stamped on hospitals, research towers, and entire pharmaceutical districts; on the frontier, it’s printed on emergency kits, cryo-sleep injectors, and the last dose of stabilizer keeping a colonist alive.
Their reputation is built not on ideology or allegiance, but clinical ubiquity. Interdyne doesn’t plant flags or claim sectors; it offers licensing, supplies, and medical infrastructure with the same practiced detachment whether the client flies SolFed banners or Syndicate colors (so long as they can pay, Interdyne delivers).
Their flagship drug, Sansufentanyl, is widely credited with slowing (though not curing) the spread of Hereditary Manifold Sickness, a condition particularly common among early colonization bloodlines. The fact that Interdyne developed the treatment, holds exclusive production rights, and may have played a role in the disease’s emergence is a conspiracy whispered more often than spoken aloud (and one the company shows no interest in acknowledging).
Where other Sovereign Corporations pursue expansion through territory, firepower, or anomaly exploitation, Interdyne’s dominance comes through treatment dependencies, embedded systems, and regulated exclusivity. Whether in a clean Core clinic or a half-frozen frontier triage pod, Interdyne is there; Not to lead, not to govern, but to ensure no one else holds the prescription pad.
History
“Origins in profit, not philanthropy.”
Interdyne Pharmaceuticals emerged sometime after the creation of faster-than-light travel on Terra, during the first serious wave of interstellar colonization. It was not born from idealism, nor from any humanitarian push to heal the expanding population, but from a sharp-eyed interest in the growing medical demands of deep-space life (and how best to profit from them).
Unlike other early corporations that sought prestige through terraforming or exploration, Interdyne carved its place through research, specifically into the then-mysterious rise of Hereditary Manifold Sickness (HMS). While other institutions scrambled to understand the condition or dismissed it as colonial myth, Interdyne moved fast, establishing specialized labs and funneling resources into human genetic profiling. The result was Sansufentanyl, the first viable long-term treatment for symptoms, and a drug that would define their legacy.
The speed of this breakthrough raised eyebrows. The medication was unnervingly well-matched to the illness. Critics argued that Interdyne may have known more than they let on, or worse, played a role in its emergence. But as the company’s profits surged and their laboratories became the gold standard for bio-clinical precision, those critics either faded from public view or stopped speaking entirely. As a Sovereign Corporation, Interdyne faced no formal investigations and issued no apologies.
With the treatment under exclusive license, Interdyne grew fast - “too fast,” some said - mirroring the explosive trajectory of Nanotrasen. They outpaced rival biotech firms, absorbed competitors, and embedded themselves in Core Sector hospitals before the public ever realized they had a monopoly. When their market dominance reached a threshold, Sovereign status followed, not through political leverage, but sheer economic gravity. It was no longer viable for governments or corporate interests to refuse doing business with Interdyne.
Yet as the company expanded, so too did its internal philosophy. The cold profiteering that defined its founding years began to refine itself into a doctrine of detachment. In the modern era, Interdyne does not present itself as a benevolent healer nor a malevolent schemer. It simply offers medicine to those who need it, at scale, at cost, and without moral entanglement.
Today, the company’s presence is split. In the Core, it is surgical in its presentation: clean clinics, towering hospitals, pristine autodocs and boardrooms lined with white marble and reinforced glass. On the Frontier, it is no less precise but markedly more somber. Facilities are often compact and utilitarian, focused on maximum efficiency over comfort. Outposts operate with reduced staff and limited amenities under strict protocol adherence, prioritizing clinical output over personnel well-being. Field stations may be spartan yet remain clean, controlled and meticulously maintained - reflecting a corporate ethos that sees luxury as waste when treating patients hundreds of light-years from oversight. Interdyne doesn’t need to impress out there; it only needs to function, and it does - relentlessly.
To the average person, Interdyne is just another Sovereign logo stamped on the pill bottle or clinic wall. Its name is as common as running water, and just as unquestioned.
Branches
Interdyne Pharmaceuticals is organized into a number of tightly focused branches, each operating with minimal cross-communication to preserve operational integrity, information security, and legal insulation. Every branch functions with near-total autonomy, reporting upward only to Central Administration. Some operate in the light, others are optimized for silence.
- Central Administration handles macro-level oversight, executive delegation, and Sovereign interfacing.
- Research leads Interdyne’s efforts in experimental sciences, xenobiology, and virology, especially prolific in unregulated Frontier zones.
- Private Security oversees the contracting of external protection assets, typically drawn from independent PMCs under strict compliance protocols.
- Pharmaceutics develops, manufactures, and distributes Interdyne’s compound library, often through third-party proxies and shareholder-controlled firms.
Each branch contributes to Interdyne’s unified goal: clinical dominance, scalable containment, and persistent growth regardless of region, law, or casualty.
Central Administration
“Continuity, not charisma.”
At the core of Interdyne’s sprawling operations is Central Administration, the governing body responsible for corporate continuity, strategic policy, and internal regulation. Unlike the theatrical “executive boards” of other Sovereign Corporations, Central Administration maintains a deliberately sterile image. There are no public-facing personalities, no press conferences, and rarely any names attached to decisions. Policies arrive signed only with branch codes and embedded approval hashes; faceless, authoritative, and final.
Central Administration is headquartered in the Core Sectors, operating from a clinical vertical complex known simply as Facility Zero. It is believed to house the primary legal and financial divisions, high-level biomedical archives, and executive arbitration rooms. Access to the facility is restricted even among Interdyne staff; most interaction with Central Administration comes through automated directives and cold correspondence, not personal audiences.
This branch oversees:
- Sovereign compliance and legal immunity
- Budget allocation and internal restructuring
- Security doctrine and personnel clearance levels
- Strategic product launches (e.g. new drug rollouts, system-wide licensing)
- Blackbook trials and unlisted field projects
Central Administration does not rule Interdyne through ideology or charisma, it simply ensures the machine keeps running, free of interruption or interference. It is not known for innovation or outreach. Its role is continuity.
Research
“The science behind the signature.”
The Research Division of Interdyne Pharmaceuticals is the foundation of the company’s scientific advancement, driving forward everything from drug development to biotechnical experimentation. Operated through a network of compartmentalized Clinical Nodes, the division is structured to maintain strict internal silos, where most researchers work in isolation, unaware of broader objectives. All intellectual property and outcomes are owned in full by Interdyne; public disclosure is both rare and tightly managed by Central Administration.
Interdyne’s most public achievement – the creation of Sansufentanyl – originated here, but that compound represents only a fragment of the division’s capabilities.
Two of its more closely guarded focus areas are Xenobiology and Virology.
In Xenobiology, Interdyne specializes in the cultivation and study of non-terrestrial lifeforms with unusual regenerative or mutagenic properties. The most notable of these are colloquially referred to as slimes (adaptable, bio-reactive organisms that can be selectively bred for undisclosed purposes). Whether used in synthetic organ scaffolding, biochemical harvesting, or something more experimental, these creatures are considered high-value research assets. Handling protocols are extensive in the Core.
Virology, meanwhile, extends far beyond traditional immunology. Interdyne’s virologists are tasked with identifying, dissecting, and in many cases designing pathogenic agents. While officially labeled as preventive research, this branch has been repeatedly accused of experimenting with controlled outbreaks, tailored immunodeficiencies, and synthetic viral models with unclear applications. None of these claims have been substantiated in any court and likely never will be.
While Core-based Clinical Nodes operate under rigid procedural oversight, Frontier research sites follow a different doctrine. There, the Research Division functions with a degree of freedom rarely seen in corporate science. Protocols are fluid, oversight is minimal, and projects forbidden in the Core are quietly greenlit, given space to breathe and evolve. Researchers assigned to Frontier postings are often selected for their risk tolerance, creativity, and discretion.
The result is a branch that appears controlled and clean from the outside, but behind locked lab doors (particularly on the edge of settled space) pushes science in directions few others are willing to.
Private Security
“Tiered detachment in practice.”
Interdyne Pharmaceuticals does not maintain a traditional in-house security force. Instead, all physical protection, facility defense, and risk-response services are outsourced to vetted Private Military Contractors (PMCs) under tightly negotiated service contracts. This approach ensures that Interdyne can maintain legal and ethical distance from the use of force (while still preserving operational integrity across Core and Frontier installations).
PMCs contracted by Interdyne vary depending on the location and threat profile:
- Core Sector sites typically employ low-visibility, compliance-focused firms trained in asset preservation and non-lethal containment (often chosen for their professionalism and ability to blend seamlessly into Interdyne’s sterile environment).
- Frontier deployments may be handled by less conventional contractors, including former Syndicate-affiliated outfits, mercenary collectives, or sovereign-aligned enforcement groups selected for flexibility and effectiveness rather than public image.
While Interdyne does not take responsibility for the actions of its contractors, all PMC personnel operating on Interdyne grounds are required to follow Interdyne’s on-site compliance standards and are monitored via embedded reporting systems. This layered approach allows Interdyne to respond quickly to sabotage, espionage, or biosecurity breaches without directly implicating its own staff or administration.
Internally, this security model is referred to as Tiered Detachment, the principle that violence and enforcement should be performed at a contractual remove from the corporation’s intellectual core. Force is a tool, not a signature (and Interdyne ensures that it remains just that).
Critics argue this system enables deniability and shields the company from accountability during unethical operations. Interdyne’s response remains consistent: “Our role is medicine. Security is a service.”
Pharmaceutics
“Distribution through discretion”.
The Pharmaceutics Division is the most publicly visible and commercially dominant branch of Interdyne Pharmaceuticals. It oversees the manufacture, refinement, and distribution of Interdyne’s vast medicinal portfolio, including everything from basic first-aid treatments and combat stims to proprietary gene therapy kits and chronic condition suppressants. Across both the Core and the Frontier, it is Interdyne’s compounds that fill emergency kits, surgical tanks, and prescription pads.
Operations within this branch are highly automated, supported by orbital fabs, subterranean synthesis labs, and ship-mounted mobile processing units. Product distribution is tightly stratified (premium-tier treatments are reserved for Sovereign clients and coreworld clinics, while ruggedized or off-brand variants are packaged for frontier markets). Despite aesthetic differences, all flow from the same carefully protected synthesis chains.
Interdyne’s power lies not just in what it produces but in how it sells. The company holds strategic shares in dozens of smaller medical and distribution firms, quietly embedding itself across supply chains without appearing as the sole supplier. These affiliate companies (such as DeForest, a well-known Core-facing logistics and pharmacy network) often sell Interdyne-developed treatments at lowered public rates, appearing more accessible and consumer-friendly. While these firms take a modest cut, Interdyne profits twice (once through product sales, and again through shareholder returns from the very companies “undercutting” them).
This tactic allows Interdyne to:
- Maintain market dominance without brand oversaturation
- Shape pricing trends while appearing competitively undercut
- Expand into restricted or politically sensitive regions via proxies
- Offload risk and liability while retaining economic control
In the Frontier, the Pharmaceutics Division operates leaner. Facilities are streamlined, often staffed by minimal crews or automated entirely, with distribution overseen by remote logistics networks. Some compounds distributed in these zones have not undergone full Core-standard trials (though packaging may suggest otherwise).
Though Interdyne’s innovation begins in research, it is through the Pharmaceutics Division’s controlled spread and hidden partnerships that their influence becomes inescapable. In clinics where no one knows who made the drug, Interdyne still collects the profit.
Ranking Structure
All Interdyne personnel are assigned a Tier Classification, which governs what information they can access, which decisions they are allowed to make, and how they are ranked internally across divisions. While job titles vary, (Interdyne Researcher, Deck Officer, Biochemist, etc.) Tier is what determines authority.
Tiers are not necessarily tied to seniority or skill. Advancement requires clearance vetting, loyalty screening, and Central Administration approval.
Tier-6 - Central Administration (Non-Public)
Access to this level is strictly need-to-know. Names, faces, and voices are not publicly logged.
- All high-level directives originate from Tier-6.
- Most employees are never even made aware Tier-6 exists.
“Clearance Denied - Requires Tier-6 Hash Confirmation”
Tier-5 - Executive Interface
Reserved for blacksite leads, Sovereign liaisons, and corporate architects.
- May act as Executive Proxies with authority across divisions.
- Can override any lower clearance. Tied directly to Central Administration.
“Tier-5 Override Accepted. Blackbook Protocol Initiated. ID: [REDACTED]”
Tier-4 - Division Control
Oversees entire Clinical Nodes, multiple operations, or Core-linked facilities.
- Full access to division intelligence: Pharmaceutics, Xenobiology, Virology, etc.
- May redirect supply chains, cancel projects, initiate protocol-level lockdowns.
“Tier-4 Directive Issued: Reallocate Sansufentanyl to DeForest under Proxy 3C”
Tier-3 - Section Coordinator
Supervisors, Deck Officers, and Facility Leads. Oversees full departments or Frontier outposts.
- Able to classify internal incidents, issue quarantines, authorize low-grade experimentation.
- Often the highest-ranking figure on isolated stations.
“Tier-3 Clearance: Deck Officer Yassan | Node 4-B | Virology Liaison”
Tier-2 - Internal Operative
Fully inducted staff. Most researchers, miners, logistics officers, and field clinicians are here.
- Granted access to department-level data, compound handling, and active projects.
- Cannot access blacksite data or interact with restricted organisms without supervision.
“Tier-2 Clearance: Slime Handling Level 3, Virology Class-B”
Tier-1 - Peripheral Personnel
Entry-level employees. Technicians, junior researchers, logistics runners, remote workers.
- Access limited to unclassified operations, maintenance, and low-risk compounds
- May operate in controlled environments under supervision.
“Tier-1 Staff: Maintenance | Facility-08A”
Tier-0 - Observation Candidates
Non-employees under review: interns, contracted specialists, test subjects, temporary hires.
- Cannot access secured systems. Often monitored.
- Not trusted with proprietary information.
Often denoted as “Provisional” on documentation.
Notable Details:
- Tier isn’t tied to job type, a Virologist could be Tier-2 or Tier-4, depending on what strain they're allowed to work on.
- Promotion requires psychological screening, NDA layering, and blackout compliance.
- All personnel are logged in the DyneCast system, an internal registry that logs access events and anomalies per Tier level.
Occupational Titles
Interdyne personnel are assigned job titles based on their specialization and departmental function, not rank. A single occupation can span multiple Tiers depending on clearance level and assignment. The following are some of the most common and recognizable occupations across Interdyne’s branches:
Medical & Pharmaceutical
- Interdyne Medical Technician - Handles basic field care, stabilization, and administration of company-approved treatments.
- Pharmacological Engineer - Develops and refines drug compounds, manages synthesis equipment.
- Pharmaceutical Handler - Oversees storage, packaging, and classified transport of Interdyne's chemical products.
- Autodoc Specialist - Maintains and calibrates automated surgical and trauma equipment.
Research & Experimental Sciences
- Interdyne Researcher - General-purpose title for staff working in xenobiology, virology, or pharmacological R&D.
- Slime Containment Officer - Specializes in the care, breeding, and disposal of volatile xeno-organisms.
- Xenobiologist - Studies and manipulates alien cellular lifeforms; frequently involved in material testing and organ culture.
- Virology Analyst - Assigned to isolate, test, and sometimes create designer viruses under secure conditions.
- Pathological Archivist - Maintains Interdyne's disease genome records and mutational tracking databases.
Logistics & Infrastructure
- Interdyne Miner - Extracts materials vital to compound synthesis and research infrastructure, often deployed on volatile planetary bodies.
- Logistical Technician - Manages shipments, drop routing, and remote supply chain interface.
- Facility Engineer - Maintains internal power, life support, and reactor systems for nodes and research sites.
- Biohazard Disposal Agent - Responsible for cleanup and neutralization of compromised lab material, rogue organisms, and incident zones.
Command & Administration
- Deck Officer - Functions as the acting authority aboard isolated stations or Frontier outposts. Handles both logistics and crisis decisions.
- Node Controller - Oversees all activity within a Clinical Node; often a Tier-4 or above.
- Compliance Auditor - Reviews procedural adherence, examines psychological logs, and reports anomalies to Central Administration.
- Division Liaison - Represents a specific branch (e.g., Pharmaceutics) across multiple installations, often tied to Sovereign negotiations.
Other Notable Roles
- Trial Subject (Voluntary/Contractual) - Used in controlled live studies, often given temporary Tier-0 clearance.
- Courier Specialist - Transports secure vials, samples, and black-label packages across volatile systems.
- Security Consultant (Contractor) - Outsourced PMC presence; operates under Interdyne's private compliance protocols.
Notable Products
Interdyne Pharmaceuticals’ product catalog spans across legitimate biotech marvels, Frontier-use compounds, and a shadowed category of illicit weaponized tools, the existence of which the company publicly denies. While Core-aligned clinics primarily receive clean, cataloged treatments, the Frontier and Syndicate-linked markets often see prototypes, off-the-books trials, and tools whose ethical classification is left to silence.
Legal &/or Public Products
Sansufentanyl
Clinical Multi-Action Regulator
Interdyne’s flagship compound. Initially developed in response to a rare multi-systemic illness, Sansufentanyl is used today in advanced trauma kits, long-term organ support, and neurosuppressive procedures. While its formulation is proprietary and heavily protected under Tier-5 classification, rumors persist that Interdyne’s earliest cases of treatment were also its first exposure vectors. No credible alternative compound exists on the market.
Interdyne Medical MODsuit
Powered Medical Exosuit - Co-Developed with Cybersun
An ultralight modular exosuit built for rapid trauma response, evacuation, or capture. When activated, the suit injects the wearer with muscle-enhancing stimulants while activating internal leg-mounted pistons, allowing near-maximum sprint speeds with minimal strain. High power consumption and biological degradation limit use to short bursts. The suit is exclusive to Sovereign subscribers and emergency service elites. Anecdotal reports mention several users who "disappeared" after failing to maintain payment or compliance. Interdyne denies involvement.
Autodoc Series 9b
Automated Surgical Table
Standard across Core clinics, Interdyne’s Autodoc units perform full-body triage, diagnosis, and invasive surgical procedures without human intervention. Later models feature adaptive tissue correction and genetically personalized stimulant delivery.
Red Sun Balm
Indecipheres-Derived Burn Ointment
Synthesized from flora analog enzymes native to Indecipheres' subcrust flora, Red Sun Balm is widely used for rapid epidermal repair and burn trauma treatment. Known to cause lucid dreams and visual distortions in untreated batches. Still used heavily by military medics and hazardous responders.
TWitch Sensory Injector (DeForest Brand)
An autoinjector packed with Interdyne-derived stimulants, distributed under DeForest’s civilian catalog. The compound, nicknamed “TWitch”, accelerates visual perception, causing time dilation-like effects. Marketed to disaster responders and elite athletes, though often used recreationally. Side effects include neural fatigue, eye muscle strain, and paranoia.
Illegally Circulated / Syndicate-Tied Technologies
(Officially disavowed. Interdyne maintains no recognized affiliation.)
Dart Pistol
A compact injection weapon with multi-toxin compatibility. Commonly used to deliver lethal compounds in close quarters. Engineered with composite polymers to avoid detection by most station scanners. No markings traceable to Interdyne.
Romerol Reagent
A synthetic compound that implants a necrotic reanimation organ (an artificial tumor) into the subject. Upon death, this organ triggers uncontrolled revival, resulting in a zombified host capable of spreading the condition. Blacksite trials reported alarming infection chains. Formula origin unknown; Interdyne’s archives list a redacted parallel project during early xenotissue research.
Biohazardous Chemical Sprayer
High-capacity dispersal unit pre-loaded with multi-stage nerve agents and destabilizers. Causes irreversible cell breakdown, violent seizures, and cardiac failure unless immediate treatment is administered. Primarily found in Syndicate operations. Constructed from repurposed Interdyne sterilization hardware.
“Health Analyzer” (Modified)
Externally indistinguishable from Nanotrasen’s standard medical scanners. Internally fitted with a radioactive microlaser. Emits a directional burst of delayed-onset radiation tuned to incapacitate most humanoids unless protected by military-grade shielding. Used in covert assassinations and asset denials. Internal documentation refers to this unit as “Model HN-7/Collapse”.
Fungal Tuberculosis Grenade
Compact dispersal canister containing an engineered mycobacterial spore cloud. Targets lung tissue and replicates in high-oxygen environments. Leads to fatal respiratory collapse within minutes. Developed for controlled biosuppression; later repurposed by field agents.
Work in Progress: Footer subject to change at a moment's notice. Do not take a red link's presence, struck-through or otherwise, as confirmation (or denial) of their canonicity.
| Nova Sector Lore
| |
| Common Species | Humans, Tiziran, Unathi, Moths, Ethereals, Azulae, Slime Hybrids, Teshari, Synthetic Humanoids (and assorted robots), Pod Persons, Hemophages, Xenomorphic Hybrid, |
| Other Species | Genemodders (Felinids, Ice Walkers, Dwarf), Ashwalkers, Snailpersons, Ordoht (Formerly Skrell), Plasmamen, Flypeople, Vox (Primalis et al), Tajaran, Vulpkanin, Rouges (Abductorkin), Miscellaneous Species, Dullahans, Employee Golems, Changelings |
| Nanotrasen | Nanotrasen, Central Command, Emergency Response Corps |
| External Groups | The Syndicate, Interdyne Pharmaceutics, DS-2, Cargo, The Spider Clan, Tiger Cooperative |
| Nova | The Nova Sector, Indecipheres, Freyja |
| Concepts | Bluespace, Plasma, Faster Than Light Travel, Resonance ("Souls"), Death |
| SolFed | SolFed, Earth in 2565, The SolFed Armed Forces, |
